Le Lézard
Classified in: Business, Covid-19 virus
Subject: ATY

RENT LAWSUIT ALERT: Levi & Korsinsky Notifies Rent the Runway, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Dec. 1, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rent the Runway, Inc. ("Rent the Runway" or the "Company") (NASDAQ: RENT) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rent the Runway investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons or entities who purchased Rent the Runway Class A common stock in or traceable to the Company's October 2021 initial public offering. Follow the link below to get more information and be contacted by a member of our team:


RENT investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) Rent the Runway was continuing to face extraordinary business headwinds, such as transportation headwinds and labor wage rate increases, from the COVID-19 pandemic; (ii) Rent the Runway's active subscriber enrollments had sharply decelerated from the growth trajectory represented in the offering documents and, as a result, Rent the Runway was several months away from approaching its pre-pandemic levels of active subscriptions; (iii) Rent the Runway needed to substantially increase marketing and advertising costs from historical figures in order to attempt to grow its active subscriber network; (iv) Rent the Runway was suffering from ballooning fulfillment and transportation costs; and (v) as a result, Rent the Runway was suffering accelerating operational losses at the time of the initial public offering and was far less likely to achieve profitability in the near term, if ever, than represented.

WHAT'S NEXT? If you suffered a loss in Rent the Runway during the relevant time frame, you have until January 13, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171

SOURCE Levi & Korsinsky, LLP

These press releases may also interest you

at 08:40
ChromaDex Corp. , a global bioscience company dedicated to healthy aging, announced promising findings from a first-of-its kind clinical study, as reported in the peer-reviewed journal Translational Neurodegeneration by a team of scientists led by...

at 08:39
The desire to be sanitary is an old one. But the pandemic has raised cleanliness (and the awareness of cleanliness) to new heights. Individuals are aware of the impact that comes from touching a doorknob at a public restaurant or spending an hour...

at 08:37
In recent years, nearly half (41%) of Americans have come to see themselves as overweight. In addition, mental health concerns like stress and anxiety have come into the spotlight like never before. As a growing number of individuals search for ways...

at 08:35
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", "Arcturus Therapeutics", Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant...

at 08:35
Griffon Corporation ("Griffon" or the "Company") today reported results for the fiscal 2023 first quarter ended December 31, 2022. Revenue for the first quarter totaled $649.4 million, a 10% increase compared to $591.7 million in the prior year...

at 08:35
The COVID-19 pandemic has raged across the globe ? and especially the United States ? for years. Even now, heading into the fourth year since the crisis began, there continues to be an elevated level of cases and associated deaths. China reported...

News published on 1 december 2022 at 05:45 and distributed by: